Bumper Offer - Urjas oil Just @ Rs. 1 X
Rifaset Suspension is a prescription medicine that is available as a Suspension. Primarily, it is used for the treatment of Hepatic Encephalopathy. Secondary and off-label uses of Rifaset Suspension have also been mentioned below.
The optimal dosage of Rifaset Suspension is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Rifaset Suspension include Flatulence, Bloating or fullness, Constipation. Apart from the aforementioned side effects, Rifaset Suspension can also lead to other problems, which have been listed below. Normally, these side effects of Rifaset Suspension are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Rifaset Suspension has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Rifaset Suspension related warnings talks about Rifaset Suspension's effects on the liver, heart and kidney.
Some other conditions that can be affected by Rifaset Suspension are listed in the contraindications section below.
Drug reaction of Rifaset Suspension with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rifaset Suspension is considered safe while driving, and is addictive.
Rifaset Suspension is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Rifaset Suspension is used -
Moderate
Mild
Common
Is the use of Rifaset Suspension safe for pregnant women?
Rifaset should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Rifaset Suspension safe during breastfeeding?
Rifaset may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Rifaset Suspension on the Kidneys?
Rifaset does not damage the kidneys.
What is the effect of Rifaset Suspension on the Liver?
Rifaset is rarely harmful for the liver.
What is the effect of Rifaset Suspension on the Heart?
Rifaset is not harmful for the heart.
Rifaset Suspension should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rifaset Suspension unless your doctor advises you to do so -
Is this Rifaset Suspension habit forming or addictive?
Rifaset Suspension is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Rifaset Suspension does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but consume Rifaset Suspension only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Rifaset Suspension for mental disorders.
Interaction between Food and Rifaset Suspension
Taking Rifaset Suspension with food does not harm your health.
Interaction between Alcohol and Rifaset Suspension
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rifaset Suspension.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097